Ma KS - Search Results

1

Nirsevimab decreased the subsequent risk of respiratory syncytial virus infection and wheezing in the 2023-2024 RSV season.

Ma KS, Tsai SY, El Saleeby CM, Kotton CN, Mansbach JM. Ma KS, et al. Pediatr Res. 2025 Jan 9. doi: 10.1038/s41390-024-03782-4. Online ahead of print. Pediatr Res. 2025. PMID: 39789206 No abstract available.

2

Mesenchymal stem cell therapy as a game-changer in liver diseases: review of current clinical trials.

Huang WC, Li YC, Chen PX, Ma KS, Wang LT. Huang WC, et al. Among authors: ma ks. Stem Cell Res Ther. 2025 Jan 6;16(1):3. doi: 10.1186/s13287-024-04127-y. Stem Cell Res Ther. 2025. PMID: 39762946 Free PMC article. Review.

3

Increasing Incidence of Serious Head and Neck Infections Among US Children, 2018-2023.

Tsai SY, Hadley S, Growdon AS, Ma KS, Mansbach JM. Tsai SY, et al. Among authors: ma ks. J Pediatr. 2024 Dec 28:114458. doi: 10.1016/j.jpeds.2024.114458. Online ahead of print. J Pediatr. 2024. PMID: 39736376

4

External validation study of Re-SCORTEN in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.

Westmeijer M, Ebriani J, Thompson BB, Holt A, Brumbaugh B, Ma KS, Mostaghimi A, Chen ST. Westmeijer M, et al. Among authors: ma ks. Int J Dermatol. 2024 Nov 26. doi: 10.1111/ijd.17584. Online ahead of print. Int J Dermatol. 2024. PMID: 39592838 No abstract available.

5

Sodium-Glucose Cotransporter 2 Inhibitors for the Primary Prevention of Glaucoma in Patients With Type 2 Diabetes: A Target Trial Emulation.

Eng K, Zebardast N, Boland MV, Lo JE, Swaminathan SS, Friedman DS, Ma KS. Eng K, et al. Among authors: ma ks. Am J Ophthalmol. 2024 Nov 6;271:286-298. doi: 10.1016/j.ajo.2024.10.029. Online ahead of print. Am J Ophthalmol. 2024. PMID: 39515454

6

Efficacy and Safety of Sodium-Glucose Cotransporter 2 Inhibitors for the Primary Prevention of Cardiovascular, Renal Events, and Safety Outcomes in Patients With Systemic Lupus Erythematosus and Comorbid Type 2 Diabetes: A Population-Based Target Trial Emulation.

Ma KS, Lo JE, Kyttaris VC, Tsokos GC, Costenbader KH. Ma KS, et al. Arthritis Rheumatol. 2024 Oct 21. doi: 10.1002/art.43037. Online ahead of print. Arthritis Rheumatol. 2024. PMID: 39431397

7

Risk of ocular manifestations and complications in patients with systemic lupus erythematosus.

Lo JE, Ma KS. Lo JE, et al. Among authors: ma ks. Int J Rheum Dis. 2024 Oct;27(10):e15334. doi: 10.1111/1756-185X.15334. Int J Rheum Dis. 2024. PMID: 39420755 No abstract available.

8

Clinical effectiveness and safety of dupilumab in patients with chronic obstructive pulmonary disease: A 7-year population-based cohort study.

Sun CY, Tesfaigzi Y, Lee GY, Chen YH, Weiss ST, Ma KS. Sun CY, et al. Among authors: ma ks. J Allergy Clin Immunol. 2025 Jan;155(1):219-222.e1. doi: 10.1016/j.jaci.2024.09.019. Epub 2024 Oct 3. J Allergy Clin Immunol. 2025. PMID: 39368553

9

Factors Driving the Risk of Cognitive Impairment in Children With Atopic Dermatitis.

Tsai SY, Ma KS. Tsai SY, et al. Among authors: ma ks. JAMA Dermatol. 2024 Nov 1;160(11):1255-1256. doi: 10.1001/jamadermatol.2024.3004. JAMA Dermatol. 2024. PMID: 39356512 No abstract available.

10

Early-Onset Melanocytic Nevi: Cutaneous, Developmental, Psychological, and Endocrine Associations.

Tsai SY, Ma KS, Hawryluk EB. Tsai SY, et al. Among authors: ma ks. Pediatrics. 2024 Oct 1;154(4):e2024066474. doi: 10.1542/peds.2024-066474. Pediatrics. 2024. PMID: 39267600 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

172 results

Search Page

Filters